-
Je něco špatně v tomto záznamu ?
In Vitro and in Vivo Behavior of Liposomes Decorated with PEGs with Different Chemical Features
F. Mastrotto, C. Brazzale, F. Bellato, S. De Martin, G. Grange, M. Mahmoudzadeh, A. Magarkar, A. Bunker, S. Salmaso, P. Caliceti,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- biologická dostupnost MeSH
- cholany aplikace a dávkování chemie farmakokinetika MeSH
- cholesterol aplikace a dávkování chemie farmakokinetika MeSH
- fosfatidylethanolaminy aplikace a dávkování chemie farmakokinetika MeSH
- HeLa buňky MeSH
- lidé MeSH
- lipidy MeSH
- liposomy MeSH
- molekulová hmotnost MeSH
- myši inbrední BALB C MeSH
- myši MeSH
- nosiče léků farmakokinetika MeSH
- polyethylenglykoly aplikace a dávkování chemie farmakokinetika MeSH
- povrchové vlastnosti MeSH
- příprava léků metody MeSH
- simulace molekulární dynamiky MeSH
- stabilita léku MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
The colloidal stability, in vitro toxicity, cell association, and in vivo pharmacokinetic behavior of liposomes decorated with monomethoxy-poly(ethylene glycol)-lipids (mPEG-lipids) with different chemical features were comparatively investigated. Structural differences of the mPEG-lipids used in the study included: (a) surface-anchoring moiety [1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE), cholesterol (Chol), and cholane (Chln)]; (b) mPEG molecular weight (2 kDa mPEG45 and 5 kDa mPEG114); and (c) mPEG shape (linear and branched PEG). In vitro results demonstrated that branched (mPEG114)2-DSPE confers the highest stealth properties to liposomes (∼31-fold lower cell association than naked liposomes) with respect to all PEGylating agents tested. However, the pharmacokinetic studies showed that the use of cholesterol as anchoring group yields PEGylated liposomes with longer permeance in the circulation and higher systemic bioavailability among the tested formulations. Liposomes decorated with mPEG114-Chol had 3.2- and ∼2.1-fold higher area under curve (AUC) than naked liposomes and branched (mPEG114)2-DSPE-coated liposomes, respectively, which reflects the high stability of this coating agent. By comparing the PEGylating agents with same size, namely, linear 5 kDa PEG derivatives, linear mPEG114-DSPE yielded coated liposomes with the best in vitro stealth performance. Nevertheless, the in vivo AUC of liposomes decorated with linear mPEG114-DSPE was lower than that obtained with liposomes decorated with linear mPEG114-Chol. Computational molecular dynamics modeling provided additional insights that complement the experimental results.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028527
- 003
- CZ-PrNML
- 005
- 20210114154140.0
- 007
- ta
- 008
- 210105s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.molpharmaceut.9b00887 $2 doi
- 035 __
- $a (PubMed)31789523
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mastrotto, Francesca $u Department of Pharmaceutical and Pharmacological Sciences , University of Padova , via F. Marzolo 5 , 35131 Padova , Italy.
- 245 10
- $a In Vitro and in Vivo Behavior of Liposomes Decorated with PEGs with Different Chemical Features / $c F. Mastrotto, C. Brazzale, F. Bellato, S. De Martin, G. Grange, M. Mahmoudzadeh, A. Magarkar, A. Bunker, S. Salmaso, P. Caliceti,
- 520 9_
- $a The colloidal stability, in vitro toxicity, cell association, and in vivo pharmacokinetic behavior of liposomes decorated with monomethoxy-poly(ethylene glycol)-lipids (mPEG-lipids) with different chemical features were comparatively investigated. Structural differences of the mPEG-lipids used in the study included: (a) surface-anchoring moiety [1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE), cholesterol (Chol), and cholane (Chln)]; (b) mPEG molecular weight (2 kDa mPEG45 and 5 kDa mPEG114); and (c) mPEG shape (linear and branched PEG). In vitro results demonstrated that branched (mPEG114)2-DSPE confers the highest stealth properties to liposomes (∼31-fold lower cell association than naked liposomes) with respect to all PEGylating agents tested. However, the pharmacokinetic studies showed that the use of cholesterol as anchoring group yields PEGylated liposomes with longer permeance in the circulation and higher systemic bioavailability among the tested formulations. Liposomes decorated with mPEG114-Chol had 3.2- and ∼2.1-fold higher area under curve (AUC) than naked liposomes and branched (mPEG114)2-DSPE-coated liposomes, respectively, which reflects the high stability of this coating agent. By comparing the PEGylating agents with same size, namely, linear 5 kDa PEG derivatives, linear mPEG114-DSPE yielded coated liposomes with the best in vitro stealth performance. Nevertheless, the in vivo AUC of liposomes decorated with linear mPEG114-DSPE was lower than that obtained with liposomes decorated with linear mPEG114-Chol. Computational molecular dynamics modeling provided additional insights that complement the experimental results.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologická dostupnost $7 D001682
- 650 _2
- $a cholany $x aplikace a dávkování $x chemie $x farmakokinetika $7 D002757
- 650 _2
- $a cholesterol $x aplikace a dávkování $x chemie $x farmakokinetika $7 D002784
- 650 _2
- $a nosiče léků $x farmakokinetika $7 D004337
- 650 _2
- $a příprava léků $x metody $7 D004339
- 650 _2
- $a stabilita léku $7 D004355
- 650 _2
- $a HeLa buňky $7 D006367
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lipidy $7 D008055
- 650 _2
- $a liposomy $7 D008081
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a simulace molekulární dynamiky $7 D056004
- 650 _2
- $a molekulová hmotnost $7 D008970
- 650 _2
- $a fosfatidylethanolaminy $x aplikace a dávkování $x chemie $x farmakokinetika $7 D010714
- 650 _2
- $a polyethylenglykoly $x aplikace a dávkování $x chemie $x farmakokinetika $7 D011092
- 650 _2
- $a povrchové vlastnosti $7 D013499
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Brazzale, Chiara $u Department of Pharmaceutical and Pharmacological Sciences , University of Padova , via F. Marzolo 5 , 35131 Padova , Italy.
- 700 1_
- $a Bellato, Federica $u Department of Pharmaceutical and Pharmacological Sciences , University of Padova , via F. Marzolo 5 , 35131 Padova , Italy.
- 700 1_
- $a De Martin, Sara $u Department of Pharmaceutical and Pharmacological Sciences , University of Padova , via F. Marzolo 5 , 35131 Padova , Italy.
- 700 1_
- $a Grange, Guillaume $u Drug Research Program, Faculty of Pharmacy , University of Helsinki , 00014 Helsinki , Finland.
- 700 1_
- $a Mahmoudzadeh, Mohamad $u Drug Research Program, Faculty of Pharmacy , University of Helsinki , 00014 Helsinki , Finland.
- 700 1_
- $a Magarkar, Aniket $u Institute of Organic Chemistry and Biochemistry , Academy of the Sciences of the Czech Republic , 166 10 Prague , Czech Republic.
- 700 1_
- $a Bunker, Alex $u Drug Research Program, Faculty of Pharmacy , University of Helsinki , 00014 Helsinki , Finland.
- 700 1_
- $a Salmaso, Stefano $u Department of Pharmaceutical and Pharmacological Sciences , University of Padova , via F. Marzolo 5 , 35131 Padova , Italy.
- 700 1_
- $a Caliceti, Paolo $u Department of Pharmaceutical and Pharmacological Sciences , University of Padova , via F. Marzolo 5 , 35131 Padova , Italy.
- 773 0_
- $w MED00008279 $t Molecular pharmaceutics $x 1543-8392 $g Roč. 17, č. 2 (2020), s. 472-487
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31789523 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114154137 $b ABA008
- 999 __
- $a ok $b bmc $g 1608862 $s 1119707
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 17 $c 2 $d 472-487 $e 20200122 $i 1543-8392 $m Molecular pharmaceutics $n Mol Pharm $x MED00008279
- LZP __
- $a Pubmed-20210105